Protalix BioTherapeutics
PLX
$1.15
Share price
-2.54%
Change (1 day)
-58.63%
Change (1 year)
Categories
Protalix BioTherapeutics (PLX) Fails to deliver data
Key failure to deliver metrics for Protalix BioTherapeutics :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.01 M
- Last 3 months FTD volume: $0.23 M
- Last year FTD volume: $17.97 M
Failures to deliver for Protalix BioTherapeutics (PLX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Protalix BioTherapeutics (PLX) - since 2019
Volume in USD (price x number of shares), data since 2019Protalix BioTherapeutics (PLX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.22 M | -99.27% |
| 2023 | $30.31 M | 358.42% |
| 2022 | $6.61 M | -60.58% |
| 2021 | $16.77 M | 183.11% |
| 2020 | $5.92 M | 3493.03% |
| 2019 | $0.16 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $15.59 M | $35.11 M | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $1.7 M | $4.65 M | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $6.66 M | $42.47 M | 🇮🇱 Israel |